OBJECTIVES/HYPOTHESIS: Cleidocranial dysplasia is an autosomal dominant skeletal syndrome characterized by open skull sutures and clavicular hypoplasia or aplasia. It results from mutations in the transcription factor CBFA1 required for osteoblast differentiation and normal bone formation. Therefore, mutations in CBFA1 would be expected to cause conductive or sensorineural hearing loss, or both. The objective of the study was to evaluate the auditory function and head and neck manifestations of patients with cleidocranial dysplasia. STUDY DESIGN: Case series. METHODS: Patients with cleidocranial dysplasia who were identified from the case records of the Craniofacial Anomalies Center at the University of California San Francisco (San Francisco, CA) gave medical and developmental history, underwent a general physical examination and a thorough head and neck examination, and completed a comprehensive audiological evaluation. RESULTS: Four families with eight affected individuals in all and one sporadic case were studied. The nine patients showed highly variable expression of abnormalities. Head and neck examination demonstrated abnormal cranial sutures, broad nasal root, clavicular hypoplasia or aplasia, and abnormally high arched palate. Although seven of nine patients showed eustachian tube dysfunction, recurrent otitis media in childhood requiring surgical intervention was not common. Hearing loss was present in three of nine patients (33%). One patient had a 40-dB mixed hearing loss, the second had a 25-dB low-frequency conductive hearing loss, and the third had a 45-dB high-frequency sensorineural hearing loss. CONCLUSION: In patients with cleidocranial dysplasia, eustachian tube dysfunction, conductive hearing loss, and sensorineural hearing loss are common because of structural and functional changes of the temporal bone and palate. Therefore, patients with cleidocranial dysplasia should be evaluated routinely by an otolaryngologist and undergo complete audiological testing.
OBJECTIVES/HYPOTHESIS: Cleidocranial dysplasia is an autosomal dominant skeletal syndrome characterized by open skull sutures and clavicular hypoplasia or aplasia. It results from mutations in the transcription factor CBFA1 required for osteoblast differentiation and normal bone formation. Therefore, mutations in CBFA1 would be expected to cause conductive or sensorineural hearing loss, or both. The objective of the study was to evaluate the auditory function and head and neck manifestations of patients with cleidocranial dysplasia. STUDY DESIGN: Case series. METHODS:Patients with cleidocranial dysplasia who were identified from the case records of the Craniofacial Anomalies Center at the University of California San Francisco (San Francisco, CA) gave medical and developmental history, underwent a general physical examination and a thorough head and neck examination, and completed a comprehensive audiological evaluation. RESULTS: Four families with eight affected individuals in all and one sporadic case were studied. The nine patients showed highly variable expression of abnormalities. Head and neck examination demonstrated abnormal cranial sutures, broad nasal root, clavicular hypoplasia or aplasia, and abnormally high arched palate. Although seven of nine patients showed eustachian tube dysfunction, recurrent otitis media in childhood requiring surgical intervention was not common. Hearing loss was present in three of nine patients (33%). One patient had a 40-dB mixed hearing loss, the second had a 25-dB low-frequency conductive hearing loss, and the third had a 45-dB high-frequency sensorineural hearing loss. CONCLUSION: In patients with cleidocranial dysplasia, eustachian tube dysfunction, conductive hearing loss, and sensorineural hearing loss are common because of structural and functional changes of the temporal bone and palate. Therefore, patients with cleidocranial dysplasia should be evaluated routinely by an otolaryngologist and undergo complete audiological testing.
Authors: Jolie L Chang; Delia S Brauer; Jacob Johnson; Carol G Chen; Omar Akil; Guive Balooch; Mary Beth Humphrey; Emily N Chin; Alexandra E Porter; Kristin Butcher; Robert O Ritchie; Richard A Schneider; Anil Lalwani; Rik Derynck; Grayson W Marshall; Sally J Marshall; Lawrence Lustig; Tamara Alliston Journal: EMBO Rep Date: 2010-09-17 Impact factor: 8.807
Authors: Bin Yang; Cong Tian; Zhi-guang Zhang; Feng-chan Han; Rami Azem; Heping Yu; Ye Zheng; Ge Jin; James E Arnold; Qing Y Zheng Journal: PLoS One Date: 2011-07-27 Impact factor: 3.240
Authors: Teresa Matthews-Brzozowska; Dorota Hojan-Jezierska; Wawrzyniec Loba; Marta Worona; Artur Matthews-Brzozowski Journal: Open Med (Wars) Date: 2018-03-01